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Abstract
This research paper discusses oral cavity cancer, which is one of the 11th most common cancers in the world. According to newer
research, some important possible causes include smokeless tobacco, marijuana, and citrus fruits. Some research attributes it to
one’s genetic makeup and include exposure to Human Papillomavirus (HPV) and diagnosis of Diabetes mellitus, all in conjunction
with one’s age. In this research paper, each of these factors are discussed in depth, and their association with this illness is considered and debated. Review of the literature reveals that the high concentrations of nicotine found in smokeless tobacco products is
deleterious to oral health. Citrus fruits have been shown to prevent oral cancer. Multiple studies reviewed implicated HPV-16 and
HPV-18 as having a gross etiologic role in many cancers of the oropharynx and the oral cavity. The causes for this cancer have
been previously attributed to inaccurate, or unclear factors.This paper works to identify some unfamiliar factors that could quite
possibly be important risk factors for this illness. Much of this research is fairly new and requires additional studies to substantiate
the causes and help raise awareness, especially in lesser developed countries.
Introduction
Cancers of the oral cavity are the 11th most common
cancers in the world. About 145,000 deaths were estimated to have occurred in 2018 across all areas of the
globe. Etiology of most cancers that occur in the mouth
has been attributed to a complex interplay of genetic and
environmental factors, as with almost all other types of
cancer. Some of the more well known and preventable
causes include smoking and excessive alcohol consumption. However, though the rate of cigar and cigarette
smoking have trended downwards throughout the world,
the rate of cancer associated with the oral cavity has
steadily increased (Warnakulasuriya, 2020). Therefore, it
is imperative to explore the many other, less known, risk
factors that are associated with oral cancer. In the last
ten years much research has been conducted regarding
cancers that affect the oral cavity and new, surprising associations have come to light. Many of these associations
are environmental factors that can be eliminated including smokeless tobacco, marijuana, and citrus food intake.
Other associations are related to one’s genetic makeup
and include exposure to Human Papillomavirus (HPV) diagnosis of Diabetes mellitus, all in conjunction with one’s
age (Petersen, 2009).
Before one can explore the many potential causes of
oral cancer, it is important to understand the types of
soft tissue cancer that can be found in the oral cavity.
Ninety percent of all cancers found in the oral cavity
are Squamous cell carcinomas (SCC). Squamous cells
line most of the oral cavity and provide a smooth and
protective layer to the mouth. The other ten percent of
cancers that occur in the oral cavity include Verrucous
carcinomas, minor salivary gland carcinomas, Lymphomas,
and many benign tumors including granular cell tumors,
fibromas, and granulomas. Minor salivary gland tumors, as
the name suggests, affect the many minor salivary glands
that are found in the hard palate (60%), lips (25%) and
buccal mucosa (15%). Subtypes of this type of carcinoma
include adenoid cystic carcinoma, mucoepidermoid carcinoma and polymorphous low-grade adenocarcinoma.
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Lymphomas of the oral cavity develop in lymphatic tissue
found in the tonsils and the posterior 1/3 of the tongue.
Additionally, some of the benign tumors found in the
mouth have a tendency to become malignant over time
and are often excised as a precaution. The final group
of soft tissue cancer of the oral cavity includes mucosal
melanomas (Scully and Porter, 2001). These can often be
found at the vermilion border or the hard palate and can
be locally aggressive.
Dentists and oral pathologists have identified key premalignant lesions that have a strong association with SCC.
These lesions include leukoplakias, erythroplakias, oral
lichen planus, and oral submucous fibroses. The WHO
(2018) further classifies these according to degree of
dysplasia; mild, moderate, severe, and carcinoma in situ.
Leukoplakias are simply defined as a “white patch or
plaque that cannot be characterized clinically or pathologically as any other disease” (Van der Waal, 2015). It is
important to note that these lesions or patches are not
wipeable. Lesions of this nature that can be wiped away are
often fungal related like Candidiasis albicans.About 2-5% of
leukoplakias annually go on to become malignant. Dentists
and health care providers will often biopsy these lesions
and monitor them consistently for changes in color or size.
One of the biggest risk factors for malignancy is the location of lesion. Lateral borders of the tongue and the floor
of the mouth are known to be the most common areas for
malignancy to appear. Erythroplakia is defined as a “bright
red velvety patch that cannot be characterized clinically
or pathologically as being caused by any other condition”
(Van der Waal, 2015). These have a much higher malignant
potential than leukoplakias and are mostly associated with
severe dysplasia and carcinoma in situ. These will generally
be excised entirely and biopsied.
The goal of this paper is to delve into the research
surrounding some of the stronger environmental and genetic associations of oral and oropharyngeal cancers. The
topics covered will include citrus fruit intake, smokeless
tobacco use, human papillomavirus, and inflammatory
bowel diseases. Systematic reviews and meta-analysis will
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be utilized to understand the possible pathophysiology
behind these associations, along with their prevalence,
and thoughts on preventative measures.
Citrus Fruits
Oral cancer accounts for over 3% of the overall burden
of cancer globally, with an incidence of 350,000 cases in
2013. Patients with oral cancer have a poor prognosis despite advances in treatment as they continue to present
with late-stage disease. Indeed, the 5-year survival rate
for oral cancer is only 46% for men and 54% for women.
In the last 10 years, many studies have provided evidence
that a regular intake of citrus fruits is associated in prevention of oral cancer. A meta-analysis discusses results
that indicate that there is an inverse association between
citrus food intake and prevalence of oral and oral-pharyngeal cancers.
Seventeen studies were reviewed for this meta-analysis.
The authors begin the review by listing the confounders
each study controlled for. These include age, sex, BMI,
smoking status, alcohol use, and education levels. Most
studies gathered data from participants using a food frequency questionnaire. Meta-analysis was conducted by
grouping participants with an increased risk of oral cancer
based on their average citrus fruit intake. Upon statistical
analysis of the pooled results, it was determined that participants had a maximum of 50% reduction in risk of oral
cancer based on the degree of intake. (Cirmi, et. al., 2018)
The study also goes on to outline possible mechanisms
by which citrus fruits can work to combat cancer. Citrus
fruits are known to have high levels of Vitamin C. Vitamin
C has been proven to combat inflammation and damage to
DNA structures, which can initiate cancer. Furthermore,
the antioxidant properties of Vitamin C work to kill cancer cells that may be proliferating (Grosso, et. al.,2013).
Another hypothesis delves into the bioactive compounds
that can be found in citrus fruits.These include flavonoids,
carotenoids, and limonoids. Of these three, flavonoids are
known to reduce inflammation, risk of infection, and oxidative stress. Oxidative stress and inflammation can lead
to oxidative damage which works to initiate and promote
cancer (Ravishankar, 2013). As such, both hypotheses
conclude that the components of citrus fruits provide an
antioxidant environment for the oral cavity and pharynx.
Smokeless Tobacco
Another important area of study in regard to oral cancer
is the use of smokeless tobacco. This includes chewing
(spit) tobacco, moist snuff and other tobacco containing products that are not smoked. Many wrongfully believe that the health concerns surrounding cigars and

cigarettes are caused by the ‘smoke’ element. Thus, they
believe chewing tobacco and snuff are a safer alternative.
Nicotiana rustica and Nicotiana tabacum are the two
major varieties of tobacco. Nicotine, a volatile alkaloid, is
the most essential component obtained from the leaves
of this herb. Nicotine is one of the most stimulating and
harmful substances on the market. Nicotine affects all
organs, and can bind to CNS receptors, and raises brain
dopamine levels, rendering it a highly addictive substance.
Muthukrishnan et al states, “Chewing tobacco and other
smokeless tobacco products are known to be deleterious
to oral health.” His group has done much research in this
field showing that smokeless tobacco has more deleterious negative effects on the oral cavity, in comparison
to their smoke-fueled counterpart. They further detail
the main health risks associated with smokeless tobacco,
namely, oral squamous cell carcinoma (SCC), verrucous
carcinomas, and tobacco-induced oral mucosal leukoplakia (Muthukrishnan , 2018).
Not only do SLTs contribute to cancer risks through their
nicotine content, but they can also increase this risk by the
oral abrasion they cause. Many abrasives are added to SLTs
in order to accelerate nicotine absorption through oral mucosa. These abrasives wear down enamel, dentin and root
surfaces along with the sensitive mucosal lining. Prolonged
trauma to these sites can create irritation fibromas that have
an increased malignant potential (Janbaz, 2014).
To further this idea, it has been documented by WHO
that the country with the highest prevalence of oral and
oropharyngeal cancer in the last 10 years is India. Oral
cancer incidence rates in many parts of India surpass 6
per 100,000 males, and in some areas, they are as high as
10.8 per 100,000. About one-half of all tobacco used in
India is smokeless tobacco, and nearly 100 million people
use smokeless tobacco products daily. A study was conducted on this subject in India from October–November
2003. Indian smokeless tobacco products that were
bought from retail stores in Gujarat, Karnataka, and
Mumbai, India were quantified. Each purchase’s date and
location, as well as the batch number, were recorded. The
32 labels that were gathered for research are items that
are widely used in India. There were also five common
brands of non-tobacco chewing mixtures (supari) included. Analysis of both groups of recreational chewing products concluded that the SLT products not only had high
levels of nicotine, but also excessively high levels of nitrosamines (nitrates), in comparison to levels of nitrates we
have in foods like cold cuts and hot dogs. Nitrosamines
are known to be carcinogenic in high volumes, as so may
be contributing to the risk of oral cancer along with the
nicotine. (Stepanov, 2005)
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To reduce the morbidity and mortality associated with
the use of these drugs, immediate public health interventions are needed. It is both ironic and disheartening
to realize that many third-world countries lack so much
health literacy that people are choosing nicotine options
that are actually worse for one’s health, thinking that they
are opting for the ‘healthier’ alternative. Ideally, advocacy
campaigns to strengthen and enforce policies restricting
SLT and smoking are needed in most of Southeast Asian
countries, but these efforts require more resources,
which many countries just cannot support at this time.
Human Papillomavirus
The Human Papillomavirus is an ancient pathogen infecting epithelial tissues in amphibians, reptiles, and mammals. Its composition includes a double-stranded DNA
surrounded by a protein capsid, similar to many other
viruses on the Papovaviridae family. There are more than
thirty strains of this virus, of which a fourth are associated
with oropharyngeal cancers. The most common low risk
strains found in HPV-related oropharyngeal cancer are
HPV- 6 and 11, while the most common high-risk strains
are 16 and 18.The high-risk strains are mainly transmitted
via frequent vaginal and/or oral sex with multiple partners
and without barrier usage. The pathophysiology behind
this virus is mainly a result of its oncoprotein production.
HPV protein E6 has been shown to interfere with p53
mechanisms in the body and protein E7 interferes with
pRb tumor suppressor protein in the host. These interruptions lead to abnormal cell growth by inhibiting the
apoptosis pathways and dysregulating the cell cycle. As
such, the early HPV oncoproteins E6 and E7 are responsible for the malignant phenotype.
It is important to appreciate the nuisances between
HPV related oropharyngeal cancers and non-HPV related ones. The most critical difference can be seen in the
detection and initial manifestations. Most HPV associated
oropharyngeal cancers begin with a protruding neck mass,
while non-HPV related ones often begin with symptoms
of sore throat and dysphagia. Research has also shown
that oropharyngeal cancers associated with HPV have
a much better prognosis, but the end-term side-effects
can be more drastic (Timbang, 2019). As the oropharynx
regulates speech, swallowing reflexes, and airway patency, surgery or other medical treatments in the area pose
substantial risk of morbidity. Standard treatment for HPV
related oral and oropharyngeal cancers is currently chemotherapy, radiation and sometimes surgery.The after-effects of these procedures often wreak havoc on the oral
cavity. Xerostomia, worsening periodontal condition, loss
of taste, trismus and osteoradionecrosis are only some of
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the risks involved after treatment.
Several studies have looked into the prevalence of
HPV in oropharyngeal cancers, but HPV identification
rates vary widely based on the population, subsite combinations, specimen type, and detection process. HPV
is more commonly seen in oropharyngeal and tonsillar
cancers than in other head and neck cancers. One study
provides a clear and insightful connection between HPV
and oropharyngeal cancer (Herrero, 2003). From April
1996 to December 1999, the research was conducted in
Italy, Spain, Northern Ireland, Poland, India, Cuba, Canada,
Australia, and Sudan. Patients were recruited from cancer
referral clinics, and control groups were drawn from the
same clinics or nearby general hospitals that served the
same populations as the case patients. Control subjects
were chosen based on sex and were within a 5-year age
gap from the case participant. Control participants were
disqualified if they had a history of oral cavity or oropharyngeal disease.
Their methods included obtaining an interview, collecting exfoliated oral cells, bloodwork, and biopsy specimen
from all case patients. HPV DNA was detected by polymerase chain reaction testing (PCR). The results indicate
that HPV DNA was detected in 3.9% of biopsy specimens
of 766 cancers of the oral cavity and of 142 cancers of the
oropharynx. HPV DNA in cancer biopsy specimens was
detected more frequently among subjects who reported
more than one sexual partner or who practiced oral sex.
HPV-16 DNA was found in 94.7% of HPV DNA-positive
case patients. Their conclusion was that HPV, especially
strain HPV-16, plays an important etiologic role in many
cancers of the oropharynx and the oral cavity. However,
there is still uncertainty regarding the mechanism of
transmission, that requires further investigation.
In the last ten years much headway has been made in
terms of prevention of HPV-related cancers of the oropharynx and oral cavity. Public health campaigns have been
instituted to increase barrier contraceptive use when engaging in oro-genital intercourse. Much of this is based on
the vast amount of research implicating HPV16 and 18
in cancers of the oral cavity and oropharynx. These campaigns are especially geared towards older adults who
are beyond the vaccination age. In terms of vaccination,
the first vaccine related to HPV was released in 2006
by the CDC and called Gardasil-4. This vaccine protects
against the four main strains implicated in HPV-related
cervical cancer in women. Recently a newer version of
this vaccine was released, preventing against 9 different
strains, and covering over 90% of strains implicated in
cervical cancer. The initial roll out of this vaccine was
geared towards boys and girls ages 9-26, with the optimal
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administration at 11 or 12 years of age. The idea behind
this was to administer the vaccine prior to initiation of
sexual activity and at an age when the body has the strongest immune response. Since then, the age recommendation has increased to 45 years old, though its efficacy at
this older point in life is exceedingly less.
It is important to note that the CDC has not approved
the vaccine for fighting oropharyngeal cancers related to
HPV. This stems from a broad lack of knowledge in the
medical world regarding cancers of the head and neck.
When surveyed, 15.5% of members of the Louisiana
Chapter of the American Academy of Pediatrics were
not aware of the link between oral cancer and HPV, and
less than half knew its prevalence in this country (Mehta,
2017). One of the main reasons the CDC has chosen not
to endorse vaccines for HPV related oral cancers is because this type of cancer may not develop for many years
after initial infection with the virus. As such, clinical trials
establishing correlation between increasing vaccine use
and decreasing oral cancer rates may be exceedingly difficult. Another critical distinction between oral and cervical cancers related to HPV is detection. Papanicolaou
tests for cervical cancer are administered regularly and
with high accuracy. No similar test with the same acuity is
available for oropharyngeal cancers. As such, this vaccine
may be the strongest form of prevention.
Inflammatory Bowel Diseases
Inflammatory bowel diseases has also been associated
with oral cancers. Inflammatory bowel disease (IBD)
refers to two diseases, Crohn’s disease, and Ulcerative
Colitis, under which the gastrointestinal (GI) tract is inflamed over a long time. While the exact cause of IBD is
unclear, it is caused by a malfunctioning immune system.
To defend the body, a fully functioning immune system destroys infectious species such as viruses and bacteria. The
immune system reacts inappropriately to environmental
stimuli in IBD, resulting in gastrointestinal inflammation.
There tends to be a genetic factor as well, with someone who has a family history of IBD being more likely to
have this abnormal immune response. Much research has
been conducted on this subject in relation to the field of
dentistry to understand oral manifestations of IBD, and if
there are any links between the disease and oral/oropharyngeal cancer.
One study, compared subjects with Ulcerative Colitis
and Crohn’s Disease in comparison to a healthy control
group. The goal of this study was to understand whether IBD has an effect on the oral cavity. The case group
was divided into five classes based on their medication
and treatment regimen: untreated, salicylate treatment,

corticosteroid therapy, immunosuppressant medications
(azathioprine and cyclosporine), and biological therapy (infliximab and adalimumab). Patients who agreed to
participate in the study completed a structured questionnaire that asked about their age, ethnicity, medical
background, medications, smoking habits, and oral hygiene
habits. Patients were also asked to mention any unusual
oral manifestations they experience, such as xerostomia,
halitosis, dysphagia, regurgitation, and dysgeusia, as well as
other signs of oropharyngeal cancer.
The results garnered indicate a higher incidence of oral
manifestations as well as oral and oropharyngeal cancer
in the case group vs the control group, though statistical
significance was not achieved. They also noted that the
majority of complications were seen in the corticosteroid and immunosuppressant therapy groups. However,
the authors state, somewhat confusingly, that the pharmacological therapy of IBD did not show a statistically significant relation with the presence of lesions of the oral
mucosa or oral cancer (Laranjeira, 2015). This is difficult
to understand when the untreated group did not show
any signs of oral manifestations. As such, much of this data
fails to serve clinical significance.
A recently published systematic review on this topic
works to provide a pathophysiology behind IBD and
cancers of the oral cavity and oropharynx. Their search
strategy included PubMed, Embase, and Scopus articles
on this topic from 1946 to January 2015, published in
any language. The results of this study indicate that the
connection between IBD and oral cancers are the extensive use of immunosuppressive drugs in this patient
population. “Immunosuppressants may promote cancers
by various mechanisms including carcinogenic mutations
of cell DNA, impaired immunosurveillance of tumor cells,
impaired number or function of immune cells chronically
infected by Epstein-Barr Virus [EBV] or HPV, and several
others (Katsanos, 2016).”
As such, prolonged immunosuppression for chronic
graft-vs-host disease or IBD increases the risk of oral
cancer. It is important to note that oral cancerous and
precancerous lesions have been reported in patients with
IBD as reported for other groups of immunosuppressed
or transplanted patients. Unfortunately, there are no
precautions implemented to modify this risk and there
are no routine oral cancer screenings recommended for
this patient population. It would behoove the medical and
dental communities to collaborate on ways to manage
the increased risks faced by people undergoing immunosuppressant treatment for IBD and other conditions
involving immunosuppression.
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Conclusion
Many lesser known and novel causes of oral cancer and
oropharyngeal cancer were discussed in this literature
review. The purpose of this was to broaden our understanding of the disease and consider possible etiologies
that had not been associated with the oral cavity in the
past. With this knowledge, we can better educate the
public in preventative measures as well as encourage
more routine screenings for those practicing higher risk
behaviors. As the saying goes, prevention is the best form
of treatment.
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